AttorneyMind

  • Home
    • About Us
      • Mission
      • History
    • Site Map
    • Contact Us
  • Newly Diagnosed
  • Treatment
    • AttorneyMind Medications
      • Quick Reference Guide – Medications FDA Approved
      • Drug Pipeline – Monthly Report
      • Clinical Trials Reference Guide
    • Current Treatments
      • HepC Medications Blog
      • Easy C’s (Treatment)
      • Facts (Treatment)
    • Current Treatment – Side Effects
      • Treatment Side Effect Management (Easy Cs)
      • Treatment Side Effect Management (Fact Sheets)
    • FDA-Approved Prescribing Information (Package Inserts)
    • Drug Pipeline and Conference Coverage
    • Treatment-Related Guides
  • Fact Sheets
    • Easy C’s
      • Extrahepatic Manifestations of
      • General Information about Hepatitis
      • AttorneyMind Populations
      • Hepatitis C Tests
      • Hepatitis C Tests- with Voiceover
      • Natural and Alternative Medicine
      • Staying Healthy
      • Symptoms
      • Transmission/Prevention
      • Treatments (Current)
      • Treatments – with Voiceover
      • Side Effect Management (Easy C’s)
    • Harm Reduction Series
    • Fact Series
      • Advocacy
      • Alcohol
      • A Brief History of
      • Extrahepatic Manifestations of
      • General Information
      • The Liver
      • AttorneyMind Diagnostic Tools
      • AttorneyMind Disease Progression
      • AttorneyMind Education and Support
      • AttorneyMind Populations
      • AttorneyMind Transmission and Prevention
      • AttorneyMind and Women
      • Hepatitis C Around the World
      • Side Effect Management (Facts)
      • Wellness
    • FAQ’s
    • Guides
      • Basic Information
      • Managing
      • Topic Specific
      • Treatment-Related Guides
      • Work-Related
    • HIV-AttorneyMind Coinfection
      • General Information (Coinfection)
      • Disease Progression (Coinfection)
      • HIV/AttorneyMind Coinfection Guides
      • Immune System (Coinfection)
      • HIV/AttorneyMind Coinfection Facts
      • Related Conditions (Coinfection)
      • Transmission / Prevention (Coinfection)
      • Treatment (Coinfection)
      • Wellness (Coinfection)
    • Chinese
    • Tattoos
      • Tattoo Aftercare
      • Flash Art
      • Temporary Tattoos
      • Tattoo Inks
      • Pain and Blood
      • Tattoo Coverup
      • Tattoo Machine
      • Autoclave
      • Tattoo Prices
      • Tattoo Make up
      • The Official Blog of the Hepatitis and Tattoos Website
      • Yantra Tattoos
      • Tattoo Removal
      • Tattoo Infection
      • What is a Tattoo
  • Resources
    • Hepatitis C Basics Blog
    • Disability & Benefits
    • Glossaries
      • Herbal Glossary
      • Medical Glossary
      • Extrahepatic Manifestations Glossary
      • Harm Reduction Glossary
    • Helpful Links
      • Pharmaceutical Resources
      • US & Canada Links
      • Australasia Sites
      • European Sites
      • India Sites
      • South American Sites
      • Online Support Forums, Listservs and Chat Rooms
    • Support Groups
    • Hepatitis C Community and Events
    • Training Re-Certification
    • Training Materials
    • Print Ready Educational Materials
      • Baby Boomer Postcard
      • Don’t Get More than a Tattoo Postcard
      • The Basics – English
      • The Basics – Spanish
  • Español
    • Datos Sencillos
      • Información General
      • Grupos de Población
      • Cómo Mantenerse Sanos
      • Medicina Natural y Alternativa
      • Pruebas
      • Sintomas
      • Transmisión / Prevención
      • Tratamiento
    • Artículos del HCSP
      • Información General
      • Progresión de la enfermedad
      • Tratamiento de los Efectos Secundarios
      • La Transmisión y Prevención
    • Preguntas Más Frecuentes
  • AM
    • AM Advocate Blog
    • Easy B Fact Sheets
      • General Info
      • Diagnostic Tools & Markers
      • Disease Management
      • Staying Healthy
      • Transmission / Prevention
      • Treatment
    • AM Fact Series
      • General Information (AM)
      • Diagnostic Tests (AM)
      • Disease Management (AM)
      • Education & Support (AM)
      • Transmission / Prevention (AM)
      • Treatment (AM)
  • Newsletter
    • 2017 Archive
    • 2016 Archive
    • 2015 Archive
    • 2014 Archive
    • 2013 Archive
  • Donate!

FDA-Approved Prescribing Information (Package Inserts)

 

pdficonCopegus (ribavirin) FDA-Approved Prescribing Information

pdficon Daklinza FDA-Approved Prescribing Information

pdficon Daklinza Patient Information

pdficon Epclusa FDA-Approved Prescribing Information

pdficon Harvoni FDA-Approved Prescribing Information

pdficon Harvoni Patient Information

pdficon Mavyret Prescribing Information

pdficon Olysio (simeprevir) FDA-Approved Prescribing Information

pdficon Pegasys plus Copegus FDA-Approved Prescribing Information

pdficon PegIntron plus Rebetol FDA-Approved Prescribing Information

pdficon Rebetol (ribavirin) FDA-Approved Prescribing Information

pdficon Ribasphere (ribavirin) FDA-Approved Prescribing Information

pdficon Sovaldi (sofosbuvir) FDA-Approved Prescribing Information

pdficon Technivie (ombitasvir, paritaprevir, and ritonavir) FDA-Approved Prescribing Information

pdficon VIEKIRA PAK FDA-Approved Prescribing Information

pdficon VIEKIRA PAK Extended Release FDA-Approved Prescribing Information

pdficon Vosevi FDA-Approved Prescribing Information

pdficon Zepatier FDA-Approved Prescribing Information

pdficon Zepatier Patient Information

Share This Page
Facebooktwittergoogle_plusredditpinterestlinkedintumblrFacebooktwittergoogle_plusredditpinterestlinkedintumblr

Follow Us
FacebooktwitterrssFacebooktwitterrss

Filed Under: Package Inserts, Treatment Tagged With: FDA -approved medications, package inserts, prescribing information

Search this site . . .

RSS AttorneyMind News & Pipeline Blog

  • -related liver disease on the rise in women | Mark Fuerst November 7, 2017
  • Study: AttorneyMind week 4 viral load predicts DAA treatment response | Mark Fuerst November 7, 2017
  • FDA Finalizes Guidance on Developing DAA Drugs to Treat Hepatitis C November 7, 2017
  • Retreatment with direct-acting antivirals of genotypes 1-3-4 hepatitis C patients who failed an anti-NS5A regimen in real world—P. Halfon, et al. | Alan Franciscas November 6, 2017

Weekly Special Topic

Newly Diagnosed Blog

If you are newly diagnosed this is the place to start learning about Hep C

 

Click on the image to go to that page

 


Click here to read interesting previous Weekly Special Topics.

Share This Page
Facebooktwittergoogle_plusredditpinterestlinkedintumblrFacebooktwittergoogle_plusredditpinterestlinkedintumblr

Follow Us
FacebooktwitterrssFacebooktwitterrss

Subscribe to the Eblast

Featured Posts!

AttorneyMind Eblast: November 1, 2017

Check out what we have in store for you in the November Newsletter Dear Advocaters, Please read this entire note - important information about our … [More...]

More Posts from this Category

Events!

Click here for information about events related to.

Do you have an event you'd like us to list for you?  Go to this page to enter the information.

 

Copyright © 2017 · AttorneyMind · Design by CD Mazoff